Literature DB >> 17989419

Arthrofibrosis of the knee.

David Magit1, Andy Wolff, Karen Sutton, Michael J Medvecky.   

Abstract

Better understanding of surgical timing, improved surgical technique, and advanced rehabilitation protocols has led to decreased incidence of motion loss after anterior cruciate ligament injury and reconstruction. However, motion loss from high-energy, multiligament injuries continues to compromise functional outcome. Prevention, consisting of control of inflammation and early motion, remains the key element in avoiding motion loss. However, certain techniques, such as manipulation under anesthesia in conjunction with arthroscopic lysis of adhesions, are reliable treatment options. Open surgical débridement is rarely necessary and should be considered only as a salvage procedure. A greater understanding of the pathogenesis of arthrofibrosis and related inflammatory mediators may result in novel therapies for treating the patient with motion loss.

Entities:  

Mesh:

Year:  2007        PMID: 17989419     DOI: 10.5435/00124635-200711000-00007

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  47 in total

1.  Acute, simultaneous tear of patellar tendon and ACL: possible mechanism of injury and rationality of the two-stage surgical treatment.

Authors:  Nikolaos E Koukoulias; Panagiotis Koumis; Alexis Papadopoulos; Dimitris Kyparlis; Stergios G Papastergiou
Journal:  BMJ Case Rep       Date:  2011-08-04

Review 2.  Arthrofibrosis after ACL reconstruction is best treated in a step-wise approach with early recognition and intervention: a systematic review.

Authors:  Seper Ekhtiari; Nolan S Horner; Darren de Sa; Nicole Simunovic; Michael T Hirschmann; Rick Ogilvie; Rebecca L Berardelli; Danny B Whelan; Olufemi R Ayeni
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-03-04       Impact factor: 4.342

3.  Results of arthroscopic adhesiolysis and manipulation in the stiff knee secondary to septic arthritis and inflammatory arthritis.

Authors:  Angel Checa; Hala Eid; Gerald Falasca; David Feinstein; Rany Al Haj
Journal:  Rheumatol Int       Date:  2009-01-16       Impact factor: 2.631

4.  Static progressive stretch improves range of motion in arthrofibrosis following total knee arthroplasty.

Authors:  Peter M Bonutti; German A Marulanda; Mike S McGrath; Michael A Mont; Michael G Zywiel
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-14       Impact factor: 4.342

5.  Extension gap needs more than 1-mm laxity after implantation to avoid post-operative flexion contracture in total knee arthroplasty.

Authors:  Shigetoshi Okamoto; Ken Okazaki; Hiroaki Mitsuyasu; Shuichi Matsuda; Hideki Mizu-Uchi; Satoshi Hamai; Yasutaka Tashiro; Yukihide Iwamoto
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-01-31       Impact factor: 4.342

6.  Increased Risk of Revision, Reoperation, and Implant Constraint in TKA After Multiligament Knee Surgery.

Authors:  Steven I Pancio; Paul L Sousa; Aaron J Krych; Matthew P Abdel; Bruce A Levy; Diane L Dahm; Michael J Stuart
Journal:  Clin Orthop Relat Res       Date:  2017-01-13       Impact factor: 4.176

7.  [Arthroscopic treatment of arthrofibrosis after ACL reconstruction. Local and generalized arthrofibrosis].

Authors:  H O Mayr; A Stöhr
Journal:  Oper Orthop Traumatol       Date:  2014-02-09       Impact factor: 1.154

8.  [Arthroscopic arthrolysis for the treatment of movement disorders of the knee].

Authors:  M Tröger; M Holschen
Journal:  Oper Orthop Traumatol       Date:  2014-08-08       Impact factor: 1.154

Review 9.  Gene Delivery to Joints by Intra-Articular Injection.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Hum Gene Ther       Date:  2018-01       Impact factor: 5.695

10.  Ultrasound evidence of altered lumbar connective tissue structure in human subjects with chronic low back pain.

Authors:  Helene M Langevin; Debbie Stevens-Tuttle; James R Fox; Gary J Badger; Nicole A Bouffard; Martin H Krag; Junru Wu; Sharon M Henry
Journal:  BMC Musculoskelet Disord       Date:  2009-12-03       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.